Repulsive Guidance Molecule-a is Involved in Th17-cell-induced Neurodegeneration in Autoimmune Encephalomyelitis
Overview
Cell Biology
Molecular Biology
Authors
Affiliations
Multiple sclerosis (MS) is a chronic autoimmune disease characterized by inflammation, demyelination, and neurodegeneration in the CNS. Although it is important to prevent neurodegeneration for alleviating neurological disability, the molecular mechanism of neurodegeneration remains largely unknown. Here, we report that repulsive guidance molecule-a (RGMa), known to regulate axonal growth, is associated with neurodegeneration in experimental autoimmune encephalomyelitis (EAE), a mouse model of MS. RGMa is highly expressed in interleukin-17-producing CD4(+) T cells (Th17 cells). We induced EAE by adoptive transfer of myelin oligodendrocyte glycoprotein (MOG)-specific Th17 cells and then inhibited RGMa with a neutralizing antibody. Inhibition of RGMa improves EAE scores and reduces neuronal degeneration without altering immune or glial responses. Th17 cells induce cultured cortical neuron death through RGMa-neogenin and Akt dephosphorylation. Our results demonstrate that RGMa is involved in Th17-cell-mediated neurodegeneration and that RGMa-specific antibody may have a therapeutic effect in MS.
Gerasimova E, Beenen A, Kachkin D, Regensburger M, Zundler S, Blumenthal D NPJ Parkinsons Dis. 2025; 11(1):36.
PMID: 40021643 PMC: 11871142. DOI: 10.1038/s41531-025-00882-8.
Olejnik P, Roszkowska Z, Adamus S, Kasarello K Pharmacol Rep. 2024; 76(5):926-943.
PMID: 39177889 PMC: 11387431. DOI: 10.1007/s43440-024-00642-0.
RGMa collapses the neuronal actin barrier against disease-implicated protein and exacerbates ALS.
Shimizu M, Shiraishi N, Tada S, Sasaki T, Beck G, Nagano S Sci Adv. 2023; 9(47):eadg3193.
PMID: 37992159 PMC: 10665002. DOI: 10.1126/sciadv.adg3193.
Yu T, Huo L, Lei J, Sun J, Wang H Inflammation. 2022; 45(6):2223-2242.
PMID: 35789312 DOI: 10.1007/s10753-022-01686-1.
Tang J, Zeng X, Yang J, Zhang L, Li H, Chen R Front Immunol. 2022; 13:766099.
PMID: 35185873 PMC: 8850277. DOI: 10.3389/fimmu.2022.766099.